
The drug favipiravir shows promising results for the treatment of patients in the early stages of the novel coronavirus, said the head of the National Hematological and Infectological Institute at South-Pest Hospital János Szlávik. Trials of the in Hungary drug have recently begun following clinical studies in Japan which showed that patients treated with Avigan […]Continue reading